Sponsor or institution

Clinical trials and research at HC Biopharma Inc.

• 8Clinical trials
• 1Country

Newest trials

All recruiting trials (8)

• Cetuximab bioequivalence test in healthy men

  This study tests whether a cetuximab injection is bioequivalent to Erbitux in healthy men to see if they behave the same in the body.

  Recruiting Phase 1 HC Biopharma Inc. · Haikou, Hainan · NCT07813468

• HC010 with chemotherapy for advanced gastrointestinal cancers

  This Phase Ib test will see if adding HC010 to common chemotherapy is safe and shows early benefit for people with advanced gastrointestinal cancers.

  Recruiting Phase 1 HC Biopharma Inc. · Beijing · NCT07477743

• HC010 combined with chemotherapy for advanced lung cancer — Phase Ib dosing and safety

  This trial tests whether adding HC010 to standard chemotherapy is safe and finds the best dose in people with advanced lung cancer while looking for early signs it helps.

  Recruiting Phase 1 HC Biopharma Inc. · Guangzhou, Guangdong · NCT07381829

• HC010 as first-line treatment for PD-L1 positive advanced non-small cell lung cancer

  This will test HC010 as a single-drug first-line treatment for adults with advanced non-small cell lung cancer whose tumors have PD-L1 expression (TPS ≥1%) and do not have EGFR/ALK/ROS1 alterations.

  Recruiting Phase 2 HC Biopharma Inc. · Shanghai, Shanghai Municipality · NCT07169552

• HC006 plus a PD-1 inhibitor for advanced solid tumors

  This trial tests whether adding HC006 to a PD-1 inhibitor helps people with advanced solid tumors.

  Recruiting Phase 1 HC Biopharma Inc. · Shanghai, Shanghai Municipality · NCT06963814

• Evaluating the safety and tolerability of HC022 in healthy individuals

  This study is testing a new drug called HC022 in healthy people to see if it's safe and how their bodies handle it before it’s used in patients with lupus.

  Recruiting at 2 sites Phase 1 HC Biopharma Inc. · Beijing and 2 other locations · NCT06657703

• Evaluating HC010 for advanced solid tumors

  This study is testing a new treatment called HC010 to see if it is safe and tolerable for people with advanced solid tumors who have run out of other treatment options.

  Recruiting Phase 1 HC Biopharma Inc. · Guangzhou, Guangdong · NCT06307925

• Testing HC006 for advanced solid tumors

  This study is testing a new treatment called HC006 to see if it can help people with advanced solid tumors by targeting specific cells in their immune system.

  Recruiting Phase 1 HC Biopharma Inc. · Shanghai, Shanghai Municipality · NCT06304571

Quick answers

How many clinical trials run by HC Biopharma Inc. are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 7, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →